About Index Trending news
Analyze
Pricing
Aravis Ventures

Aravis Ventures

Aravis Ventures

venture company

Elsewhere

Alexa global traffic share

Twitter followers

Activity

Past year's investments

Aravis Ventures participated in fewer than 3 rounds over the past year.

Latest rounds

- Synosia Therapeutics: Venture capital (Series C) ($30M)
- NovImmune: Venture capital (Series C) ($54.8M)
- Ambrx: Venture capital (Series D) ($10M)

Main Co-investors

- Versant Ventures
- 5AM Ventures
- Novartis Venture Fund

Total funding
$137.2M in 4 rounds from 15 investors
By Aravis Ventures
$54.8M Series C in May, 2009
Total funding
$91.5M in 3 rounds from 18 investors
By Aravis Ventures
$30M Series C in Oct, 2010
Exit Biotie Therapies, Jan 11, 2011
Total funding
$55M in 2 rounds from 14 investors
By Aravis Ventures
$10M Series D in Apr, 2009

Want to see the complete list?
Go Pro!